2012
DOI: 10.1074/jbc.m112.343947
|View full text |Cite
|
Sign up to set email alerts
|

The Oncoprotein HBXIP Uses Two Pathways to Up-regulate S100A4 in Promotion of Growth and Migration of Breast Cancer Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
87
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 72 publications
(91 citation statements)
references
References 36 publications
4
87
0
Order By: Relevance
“…Moreover, we revealed that HBXIP was able to interact with the E-box in the promoters of c-Myc-induced genes. It further supports that HBXIP is a coactivator of transcriptional factor c-Myc, which is consistent with our reports that HBXIP is able to coactivate transcription factors, such as TF-IID, STAT3, SP1, CREB, and E2F1, in breast cancer cells (15)(16)(17)(18)(19)(20).…”
Section: Discussionsupporting
confidence: 93%
See 2 more Smart Citations
“…Moreover, we revealed that HBXIP was able to interact with the E-box in the promoters of c-Myc-induced genes. It further supports that HBXIP is a coactivator of transcriptional factor c-Myc, which is consistent with our reports that HBXIP is able to coactivate transcription factors, such as TF-IID, STAT3, SP1, CREB, and E2F1, in breast cancer cells (15)(16)(17)(18)(19)(20).…”
Section: Discussionsupporting
confidence: 93%
“…The electrophoresis mobility shift assay (EMSA) protocol was described in detail (16,17). Nuclear extracts were prepared with MCF-7 cells using the EpiQuik Nuclear Extraction Kit (Epigentek).…”
Section: Electrophoresis Mobility Shift Assaysmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, we found that HBXIP greatly upregulated FAS in breast cancer cells. Our recent work illustrated that the oncoprotein HBXIP as a transcription coactivator appeared to play a crucial role in promoting the development of breast cancer (16,(22)(23)(24). Accordingly, we hypothesized that the HBXIP might be involved in modulating FAS transcription.…”
Section: Discussionmentioning
confidence: 96%
“…Previously, we reported that HBXIP acted as an oncogenic coactivator for transcription factors in breast cancer (16,(22)(23)(24). Accordingly, we performed chromatin immunoprecipitation (ChIP) assays to determine whether HBXIP was involved in the transcriptional regulation of FAS.…”
Section: Hbxip Activates Fas Through Upregulation Of Srebp-1c Transcrmentioning
confidence: 99%